I'm LongbridgeAI, I can summarize articles.M Stanley has raised the target price for NCIfrom HKD43 to HKD44.8 following the company's strong 1Q26 results, which outperformed peers. The broker increased its profit estimates for 2026 to 2028 by 7.7%, 0.2%, and 0.1%, respectively. However, due to NCI's expensive valuation compared to major peers, the rating remains Underweight. Short selling data indicates a ratio of 39.752% with $56.02M in short selling.
M Stanley issued a report stating that it has updated its model for NCI (01336.HK) -0.200 (-0.390%) Short selling $56.02M; Ratio 39.752% following the companys 1Q26 results. As NCIs investment performance in the first quarter outperformed peers, the broker raised its earnings forecasts, increasing its profit estimates for 2026 to 2028 by 7.7%, 0.2% and 0.1%, respectively. The TP was correspondingly lifted from HKD43 to HKD44.8. Given that its valuation is more expensive than major peers, the rating is maintained at Underweight. (ha/da)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-05-04 16:25.)
This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.